Loading organizations...
Key people at Ragnar Crossover Fund.
Ragnar Crossover Fund operates as Israel's inaugural Crossover Pre-IPO fund, specializing in late-stage private investments. It provides capital to companies preparing for public market entry, leveraging deep insights into private and public market dynamics. The fund's strategy identifies and supports high-potential ventures as they transition to public trading.
Established by partners from the Alpha hedge fund group, Ragnar capitalized on their extensive public market expertise. Founders recognized a critical Israeli market need for a specialized vehicle to address pre-IPO opportunities, effectively bridging the funding gap between late-stage venture capital and public listings.
The fund targets institutional and sophisticated limited partners seeking exposure to promising late-stage private technology companies. Ragnar's vision fosters leading Israeli innovation by supplying essential capital during final growth phases, aiming for substantial investor value through strategic selections facilitating successful public market entry.
Key people at Ragnar Crossover Fund.
Ragnar Crossover Fund has 1 tracked investment across 1 company. The latest tracked deal is $26.0M Series D in RedDress in May 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 24, 2023 | RedDress | $26.0M Series D | — | ATHOS Biopharma, HCS Capital |